Notify me when Tien-Li Lee files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| AARD | Aardvark Therapeutics, Inc. | Common Stock, par value $0.00001 | 14% | $21,303,789 | 2,983,724 | Tien-Li Lee | 31 Mar 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|